Icecure Medical (ICCM) Stock Analysis

Icecure Medical (ICCM) is a publicly traded company in the HEALTHCARE sector. It trades at $0.14, carries a market capitalization of $17.55M. This page summarizes the public market data, fundamentals, and frequently asked questions for ICCM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $0.14
• Market Cap: $17.55M
• EPS: $-0.24
• 52-Week High: $1.40
• 52-Week Low: $0.20

Market Sentiment

Icecure Medical currently has a Neutral sentiment score of 0.05.

About Icecure Medical

IceCure Medical Ltd, headquartered in Caesarea, Israel, is a pioneering medical technology firm dedicated to the development and commercialization of minimally invasive cryoablation therapies. Primarily targeting the women's health and oncology sectors, the company focuses on delivering innovative treatment solutions that enhance patient comfort and therapeutic efficacy. IceCure's commitment to advancing healthcare quality positions it favorably within the rapidly evolving medical technology ...

GNG Research Analysis

GNG Research scores Icecure Medical (ICCM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ICCM.

Frequently Asked Questions

Does ICCM pay dividends?

Icecure Medical (ICCM) does not currently pay a regular dividend.

What is ICCM's market cap?

Icecure Medical (ICCM) has a market capitalization of $17.55M with a current stock price of $0.14.